Search

Your search keyword '"Finke, JH"' showing total 156 results

Search Constraints

Start Over You searched for: Author "Finke, JH" Remove constraint Author: "Finke, JH"
156 results on '"Finke, JH"'

Search Results

1. Defining the critical hurdles in cancer immunotherapy

2. Inactivation of Complement by Loxosceles Reclusa Spider Venom

3. Effect of particle size on the dispersion behavior of magnesium stearate blended with microcrystalline cellulose.

4. Investigation of Dispersion Kinetics of Particulate Lubricants and their Effect on the Mechanical Strength of MCC Tablets.

5. Process and formulation parameters influencing the survival of Saccharomyces cerevisiae during spray drying and tableting.

6. Influence of compression kinetics during tableting of fluidized bed-granulated microorganisms on microbiological and physical-mechanical tablet properties.

7. Tableting of fluidized bed granules containing living microorganisms.

8. Enhanced multi-component model to consider the lubricant effect on compressibility and compactibility.

9. The Effect of Particle Shape on the Compaction of Realistic Non-Spherical Particles-A Multi-Contact DEM Study.

10. Effect of Process Parameters, Protectants and Carrier Materials on the Survival of Yeast Cells during Fluidized Bed Granulation for Tableting.

12. Embedding of Poorly Water-Soluble Drugs in Orodispersible Films-Comparison of Five Formulation Strategies.

13. Amorphization and modified release of ibuprofen by post-synthetic and solvent-free loading into tailored silica aerogels.

14. Influence of the drug deformation behaviour on the predictability of compressibility and compactibility of binary mixtures.

15. Evaluation of the Formulation Parameter-Dependent Redispersibility of API Nanoparticles from Fluid Bed Granules.

16. Modified release kinetics in dual filament 3D printed individualized oral dosage forms.

17. Prediction of the impact of lubrication on tablet compactibility.

18. Healthy myeloid-derived suppressor cells express the surface ectoenzyme Vanin-2 (VNN2).

19. Tablet Disintegration and Dispersion under In Vivo-like Hydrodynamic Conditions.

20. Modeling of High-Density Compaction of Pharmaceutical Tablets Using Multi-Contact Discrete Element Method.

21. Tablet formulation development focusing on the functional behaviour of water uptake and swelling.

22. Opposing Effects of Additives in Dry Milling and Tableting of Organic Particles.

23. How can single particle compression and nanoindentation contribute to the understanding of pharmaceutical powder compression?

24. The use of X-ray microtomography to investigate the microstructure of pharmaceutical tablets: Potentials and comparison to common physical methods.

25. Process Modeling and Simulation of Tableting-An Agent-Based Simulation Methodology for Direct Compression.

26. The influence of particle size on the application of compression and compaction models for tableting.

28. The immunology of renal cell carcinoma.

29. Myeloid-Derived Suppressor Cells in Nonmetastatic Urothelial Carcinoma of Bladder Is Associated With Pathologic Complete Response and Overall Survival.

30. Spray drying of API nanosuspensions: Importance of drying temperature, type and content of matrix former and particle size for successful formulation and process development.

31. Influence of Formulation Parameters on Redispersibility of Naproxen Nanoparticles from Granules Produced in a Fluidized Bed Process.

32. Blood Myeloid-Derived Suppressor Cells Correlate with Neutrophil-to-Lymphocyte Ratio and Overall Survival in Metastatic Urothelial Carcinoma.

33. Scaling Tableting Processes from Compaction Simulator to Rotary Presses-Mind the Sub-Processes.

34. Impact of Particle and Equipment Properties on Residence Time Distribution of Pharmaceutical Excipients in Rotary Tablet Presses.

35. The Challenge of Die Filling in Rotary Presses-A Systematic Study of Material Properties and Process Parameters.

36. Along the Process Chain to Probiotic Tablets: Evaluation of Mechanical Impacts on Microbial Viability.

37. Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs.

38. Characterization of the 3D microstructure of Ibuprofen tablets by means of synchrotron tomography.

39. Model-based description of disintegration time and dissolution rate of nanoparticle-loaded orodispersible films.

40. Influence of High, Disperse API Load on Properties along the Fused-Layer Modeling Process Chain of Solid Dosage Forms.

41. SOFTs - Structured orodispersible film templates.

42. A Mathematical Approach to Consider Solid Compressibility in the Compression of Pharmaceutical Powders.

43. Characterization of Mechanical Property Distributions on Tablet Surfaces.

44. Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma.

45. Formation of long-term stable amorphous ibuprofen nanoparticles via antisolvent melt precipitation (AMP).

46. Myeloid-derived suppressors cells (MDSC) correlate with clinicopathologic factors and pathologic complete response (pCR) in patients with urothelial carcinoma (UC) undergoing cystectomy.

47. Novel strategies for the formulation and processing of poorly water-soluble drugs.

48. Instant ODFs - Development of an intermediate, nanoparticle-based product platform for individualized medication.

49. MEK inhibition abrogates sunitinib resistance in a renal cell carcinoma patient-derived xenograft model.

50. Efficient production of nanoparticle-loaded orodispersible films by process integration in a stirred media mill.

Catalog

Books, media, physical & digital resources